Skip to main content
Free trial

Ask AI to review this stock

Copy the prompt to get recent events, historical reactions, and a short research brief.

Tell your AI:

Help me set up FinLab and analyze RHI Robert Half Inc.. Please read: https://finlab.finance/en/setup?stock=RHI

Open Studio

RHI

Robert Half Inc. Industrials As of 2026-08-28 Updated daily after market close

quality needs a look, premium valuation.

Valuation 35Quality 50Growth 34Momentum 83Risk / liquidity 58

Is Robert Half Inc. a buy? Fundamentals and valuation first

  • Quality is weaker than peers. Operating margin is only around the 36th percentile. TTM ROE is about 9.3%.

  • Valuation is expensive. TTM P/E is in the 87th percentile, above most peers.

  • Recent volatility is moderate. 60-day annualized volatility is near the 68th percentile. Average 20-day dollar volume is about $79.4M.

  • Signals are active now. 52-week adjusted-price high, Top-quintile 6-month momentum currently holds; the tables below show what followed in this stock’s own history.

Watchlist

This page refreshes daily after the close. Add Robert Half Inc. to your watchlist to track signal changes on your next visit.

Historical evidence

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

52-week adjusted-price high

Active

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

14 historical occurrences (since 2017-01-03)
Average forward return after 52-week adjusted-price high。20-day: Win 61.5%, Sample 13, Median +0.91%, Excess +2.15%, Beat mkt rate 61.5%;60-day: Win 76.9%, Sample 13, Median +8.35%, Excess +2.31%, Beat mkt rate 69.2%;120-day: Win 76.9%, Sample 13, Median +16.14%, Excess +7.38%, Beat mkt rate 76.9%

120 days after: historical avg +12.21%

20-day +2.54%
60-day +5.5%
120-day +12.21%
20-day
60-day
120-day
Win
61.5%
76.9%
76.9%
Sample
13
13
13
Median
+0.91%
+8.35%
+16.14%
Excess
+2.15%
+2.31%
+7.38%
Beat mkt rate
61.5%
69.2%
76.9%

Over 13 occurrences, 120-day forward avg gained 12.21%, beat the market by 7.38 pts; win rate 76.9%.

Top-quintile 6-month momentum

Active · now 94.40677966101696%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

15 historical occurrences (since 2016-12-23)
Average forward return after Top-quintile 6-month momentum。20-day: Win 33.3%, Sample 15, Median -1.47%, Excess -0.43%, Beat mkt rate 53.3%;60-day: Win 50%, Sample 14, Median +0.64%, Excess +0.73%, Beat mkt rate 50%;120-day: Win 50%, Sample 14, Median -1.44%, Excess +1.29%, Beat mkt rate 42.9%

120 days after: historical avg +2.27%

20-day +0.29%
60-day +1.61%
120-day +2.27%
20-day
60-day
120-day
Win
33.3%
50%
50%
Sample
15
14
14
Median
-1.47%
+0.64%
-1.44%
Excess
-0.43%
+0.73%
+1.29%
Beat mkt rate
53.3%
50%
42.9%

Over 14 occurrences, 120-day forward avg gained 2.27%, beat the market by 1.29 pts; win rate 50%.

Valuation regime and forward returns

Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 394+17.7% +2.6% 58.1% -4.9%
20-40 131+16.8% -12.5% 32.8% -9.1%
40-60 245-8.3% -22.5% 18.8% -24.5%
60-80 349-27.2% -34.5% 11.7% -37%
80-100 You are here278+0.8% -9.3% 45% -4%

Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.

Current TTM P/E is about 39.40, placing it in the 100.0 own-history percentile, inside the 80-100 bucket.

Valuation × momentum analogs

Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.

Valuation
Momentum
Cheap (own-history bottom third)
Middle
Expensive (own-history top third)
60-day momentum up
+5.6%
Win rate 59.3% Excess -5.8%
189d
-4.4%
Win rate 32.8% Excess -12.3%
174d
Now
+5.1%
Win rate 62% Excess +2.2%
389d
60-day momentum down
+5.6%
Win rate 58.5% Excess -2.9%
316d
-3.9%
Win rate 35.7% Excess -13.4%
345d
-29.3%
Win rate 8.7% Excess -37.6%
104d

Currently in “Expensive (own-history top third) × 60-day momentum up”: across 389 historical days, 120-day forward avg gained 5.1%, win rate 62%, beat the market by 2.2%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Market-wide momentum baseline

Across 97,367 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.31%, a 58.2% positive-return rate, and +2.95 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

10 times historically; 60-day forward avg +12.58%, win rate 90%, beating the market by +6.14 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.